Literature summary for 3.4.21.119 extracted from

Gueugnon, F.; Barascu, A.; Mavridis, K.; Petit-Courty, A.; Marchand-Adam, S.; Gissot, V.; Scorilas, A.; Guyetant, S.; Courty, Y.
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer (2015), Tumor Biol., 36, 4979-4986.

Search for more literature for 3.4.21.119

Application

Application	Comment	Organism
diagnostics	gene KLK13 mRNA expression constitutes a biomarker for the prediction of overall survival in nonsmall cell lung cancer and that its quantitative assessment in tumor tissues can aid in treatment decision making. Kaplan-Meier survival analyses demonstrate that patients with KLK13-positive tumors survive significantly longer than those with KLK13-negative ones	Homo sapiens

Cloned(Commentary)

Cloned (Comment)	Organism
gene KLK13, encoded on chromosome 19q13.4, quantitative real-time PCR expression analysis	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	Q9UKR3	gene KLK13	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
lung	-	Homo sapiens	-
non-small cell lung cancer cell	-	Homo sapiens	-

Synonyms

Synonyms	Comment	Organism
kallikrein-related peptidase 13	-	Homo sapiens
KLK13	-	Homo sapiens

Expression

Organism	Comment	Expression
Homo sapiens	the KLK13 gene is dysregulated in several carcinomas, and its expression levels seem to be associated with disease prognosis	up

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)